Holocene Advisors, LP

Position in CELC — Celcuity Inc.

CIK 1700574 New York, NY

Position in CELC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$42,229,403

-$27,123,808 QoQ

Shares Held

369,979

-46.8% QoQ

Ownership

0.759%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Holocene Advisors, LP holds $1,357,789,985 across 26 Biotechnology names. CELC ranks #11 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,468,644	$240,075,629
2	TERN	Terns Pharmaceuticals, Inc.	4,115,828	$216,986,452
3	JAZZ	Jazz Pharmaceuticals plc	733,905	$138,744,740
4	SRRK	Scholar Rock Holding Corp	1,890,927	$92,957,971
5	XENE	Xenon Pharmaceuticals Inc.	1,518,686	$88,311,590
6	COGT	Cogent Biosciences, Inc.	2,250,196	$86,610,044
7	TNGX	Tango Therapeutics, Inc.	3,932,603	$82,270,054
8	BLTE	Belite Bio, Inc	494,495	$78,842,282

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$42,229,403	369,979	-46.8%	Shares	Sole	2026-05-15
2025-12-31	$69,353,211	695,340	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.